Venture Capital
New York, New York, 10017
Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health. Since 2000, Aisling Capital has raised over $1.8 billion in committed capital across four funds. Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures. The Aisling Capital team’s combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry. Aisling Capital seeks to identify differentiated healthcare products, services and technologies that address unmet medical needs. Aisling Capital makes investment decisions driven by fundamental assessment of scientific, regulatory, financial and commercial risks. Given our investment team’s broad skillset, we invest across the life sciences, including seed.
10524sbs
